Using remote monitoring to help people reduce alcohol use
Remote alcohol monitoring to facilitate abstinence reinforcement with an underserved population
['FUNDING_R01'] · UNIVERSITY OF KENTUCKY · NIH-10482379
This study is exploring a new way to help people with alcohol use disorder by using mobile breathalyzers to check if they’re staying sober, and if they do, they can earn rewards on a debit card, making it easier and less stressful for them to get support without needing to go to in-person meetings.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KENTUCKY (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-10482379 on ClinicalTrials.gov |
What this research studies
This research investigates a new approach to support individuals with alcohol use disorder by using remote monitoring technology. Participants will use mobile breathalyzers to verify their alcohol abstinence, and they will receive incentives through a reloadable debit card for maintaining sobriety. The study aims to address barriers to traditional treatment by providing a more accessible and less stigmatizing option for those who may not seek in-person help. By leveraging technology, the research seeks to improve treatment adherence and outcomes for individuals struggling with alcohol use.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who struggle with alcohol use disorder and may have difficulty accessing traditional treatment options.
Not a fit: Patients who do not have access to the required technology or who are not willing to engage in remote monitoring may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and accessible way for individuals to achieve and maintain sobriety from alcohol.
How similar studies have performed: Previous research has shown success with similar remote monitoring approaches in addiction treatment, indicating potential for this method to be effective.
Where this research is happening
LEXINGTON, UNITED STATES
- UNIVERSITY OF KENTUCKY — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KOFFARNUS, MIKHAIL NIKOLAAS — UNIVERSITY OF KENTUCKY
- Study coordinator: KOFFARNUS, MIKHAIL NIKOLAAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.